Associations of Fetuin-A levels with vascular disease in type 2 diabetes patients with early diabetic nephropathy

Cardiovascular Diabetology

Volumn 9, Issue , 2010, Pages

  Roos, Marcel ^a   Oikonomou, Dimitrios ^b   von Eynatten, Maximilian ^a   Luppa, Peter B ^a   Heemann, Uwe ^a   Lutz, Jens ^a   Baumann, Marcus ^a   Nawroth, Peter P ^b   Bierhaus, Angelika ^b   Humpert, Per M ^b  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CHOLESTEROL; CREATININE; FETUIN A; HEMOGLOBIN A1C; ALPHA2HS GLYCOPROTEIN; BIOLOGICAL MARKER; PLASMA PROTEIN;

ADULT; AGE DISTRIBUTION; AGED; ALBUMIN BLOOD LEVEL; ALBUMINURIA; ANKLE BRACHIAL INDEX; ARTERIAL WALL THICKNESS; ARTICLE; CARDIOVASCULAR RISK; CAROTID ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; COMMON CAROTID ARTERY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CROSS-SECTIONAL STUDY; DIABETIC NEPHROPATHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLOMERULUS FILTRATION RATE; HEMOGLOBIN BLOOD LEVEL; HIGH RISK POPULATION; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MICROANGIOPATHY; NON INSULIN DEPENDENT DIABETES MELLITUS; POLYNEUROPATHY; PREDICTION; PROTEIN BLOOD LEVEL; PROTEIN URINE LEVEL; SEX DIFFERENCE; VASCULAR DISEASE; CARDIOVASCULAR DISEASE; CAROTID ARTERY DISEASE; DIABETIC ANGIOPATHY; METABOLISM; MIDDLE AGED; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PREVALENCE; RISK FACTOR; SEX RATIO; STROKE;

AGED; ANKLE BRACHIAL INDEX; BIOLOGICAL MARKERS; BLOOD PROTEINS; CARDIOVASCULAR DISEASES; CAROTID ARTERY DISEASES; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DIABETIC NEPHROPATHIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PERIPHERAL ARTERIAL DISEASE; PREVALENCE; RISK FACTORS; SEX DISTRIBUTION; STROKE;

EID: 77956473926     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-9-48     Document Type: Article

References (31)

1. St Clair L, Ballantyne CM. Biological surrogates for enhancing cardiovascular risk prediction in type 2 diabetes mellitus. Am J Cardiol 2007, 99:80B-88B. 10.1016/j.amjcard.2006.11.008, 17307060.
2. Zethelius B, Berglund L, Sundström J, Ingelsson E, Basu S, Larsson A, Venge P, Arnlöv J. Use of multiple biomarkers to improve the prediction of death from cardiovascular causes. N Engl J Med 2008, 358:2107-2116. 10.1056/NEJMoa0707064, 18480203.
3. Folsom AR, Chambless LE, Ballantyne CM, Coresh J, Heiss G, Wu KK, Boerwinkle E, Mosley TH, Sorlie P, Diao G, Sharrett AR. An assessment of incremental coronary risk prediction using C-reactive protein and other novel risk markers: the atherosclerosis risk in communities study. Arch Intern Med 2006, 166:1368-1373. 10.1001/archinte.166.13.1368, 16832001.
4. Kim HC, Greenland P, Rossouw JE, Manson JE, Cochrane BB, Lasser NL, Limacher MC, Lloyd-Jones DM, Margolis KL, Robinson JG. Multimarker prediction of coronary heart disease risk: the Women's Health Initiative. J Am Coll Cardiol 2010, 55:2080-2091. 10.1016/j.jacc.2009.12.047, 20447530.
5. Heiss A, DuChesne A, Denecke B, Grötzinger J, Yamamoto K, Renné T, Jahnen-Dechent W. Structural basis of calcification inhibition by alpha 2-HS glycoprotein/fetuin A. Formation of colloidal calciprotein particles. J Biol Chem 2003, 278:13333-13341. 10.1074/jbc.M210868200, 12556469.
6. Schafer C, Heiss A, Schwarz A, Westenfeld R, Ketteler M, Floege J, Muller-Esterl W, Schinke T, Jahnen-Dechent W. The serum protein alpha 2-Heremans-Schmid glyco-protein/fetuin-A is a systemically acting inhibitor of ectopic calcification. J Clin Invest 2003, 112:357-366. 166290, 12897203.
7. Luo G, Ducy P, McKee MD, Pinero GJ, Loyer E, Behringer RR, Karsenty G. Spontaneous cal-cification of arteries and cartilage in mice lacking matrix GLA protein. Nature 1997, 386:78-81. 10.1038/386078a0, 9052783.
8. Hermans MM, Brandenburg V, Ketteler M, Kooman JP, van der Sande FM, Boeschoten EW, Leunissen KM, Krediet RT, Dekker FW. Netherlands cooperative study on the adequacy of Dialysis (NECOSAD). Association of serum fetuin-A levels with mortality in dialysis patients. Kidney Int 2007, 72:202-207. 10.1038/sj.ki.5002178, 17342178.
9. Ketteler M, Bongartz P, Westenfeld R, Wildberger JE, Mahnken AH, Böhm R, Metzger T, Wan-ner C, Jahnen-Dechent W, Floege J. Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study. Lancet 2003, 361:827-833. 10.1016/S0140-6736(03)12710-9, 12642050.
10. Weikert C, Stefan N, Schulze MB, Pischon T, Berger K, Joost HG, Häring HU, Boeing H, Fritsche A. Plasma fetuin-A levels and the risk of myocardial infarction and ischemic stroke. Circulation 2008, 118:2555-2562. 10.1161/CIRCULATIONAHA.108.814418, 19029462.
11. Roos M, von Eynatten M, Heemann U, Rothenbacher D, Brenner H, Breitling LP. Serum Fetuin-A, Cardiovascular Risk Factors and 6-year Follow-up Outcome in Patients With Coronary Heart Disease. Am J Cardiol 2010, 105:1666-1672. 10.1016/j.amjcard.2010.01.342, 20538112.
12. Eraso LH, Ginwala N, Qasim AN, Mehta NN, Dlugash R, Kapoor S, Schwartz S, Schutta M, Iqbal N, Mohler ER, Reilly MP. Association of Lower Plasma Fetuin-A Levels With Peripheral Arterial Disease in Type 2 Diabetes. Diabetes Care 2010, 33:408-410. 10.2337/dc09-1541, 19910501.
13. Emoto M, Mori K, Lee E, Kawano N, Yamazaki Y, Tsuchikura S, Morioka T, Koyama H, Shoji T, Inaba M, Nishizawa Y. Fetuin-A and atheroclerotic calcified plaque in patients with type 2 diabetes mellitus. Metabolism 2010, 59:873-878. 10.1016/j.metabol.2009.10.005, 20015522.
14. Stefan N, Weikert C, Ix JH, Fritsche A, Häring HU. Association of lower plasma fetuin-A levels with peripheral arterial disease in type 2 diabetes: response to Eraso et al. Diabetes Care 2010, 33:e55. author reply e56, 10.2337/dc10-0002, 20351222.
15. Mehrotra R, Westenfeld R, Christenson P, Budoff M, Ipp E, Takasu J, Gupta A, Norris K, Ketteler M, Adler S. Serum fetuin-A in nondialyzed patients with diabetic nephropathy: relationship with coronary artery calcification. Kidney Int 1995, 67:1070-1077.
16. Gross JL, de Azevedo MJ, Silveiro SP, Canani LH, Caramori ML, Zelmanovitz T. Diabetic nephropathy: diagnosis, prevention, and treatment. Diabetes Care 2005, 28:164-76. Review, 10.2337/diacare.28.1.164, 15616252.
17. von Eynatten M, Baumann M, Heemann U, Zdunek D, Hess G, Nawroth PP, Bierhaus A, Humpert PM. Urinary L-FABP and anaemia: distinct roles of urinary markers in type 2 diabetes. Eur J Clin Invest 2010, 40:95-102. 10.1111/j.1365-2362.2009.02220.x, 19912308.
18. Levey AS, Coresh J, Greene T, Marsh J, Stevens LA, Kusek JW, Van Lente F. Chronic Kidney Disease Epidemiology Collaboration. Expressing the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clin Chem 2007, 53:766-72. 10.1373/clinchem.2006.077180, 17332152.
19. Humpert PM, Papadopoulos G, Schaefer K, Djuric Z, Konrade I, Morcos M, Nawroth PP, Bierhaus A. sRAGE and esRAGE are not associated with peripheral or autonomic neuropathy in type 2 diabetes. Horm Metab Res 2007, 39:899-902. 10.1055/s-2007-993155, 18046662.
20. Meijer JW, Smit AJ, Lefrandt JD, van der Hoeven JH, Hoogenberg K, Links TP. Back to basics in diagnosing diabetic polyneuropathy with the tuning fork!. Diabetes Care 2005, 28:2201-2205. 10.2337/diacare.28.9.2201, 16123490.
21. Hennige AM, Staiger H, Wicke C, Machicao F, Fritsche A, Häring HU, Stefan N. Fetuin-A induces cytokine expression and suppresses adiponectin production. PLoS One 2008, 12(3):e1765.
22. Ix JH, Shlipak MG, Brandenburg VM, Ali S, Ketteler M, Whooley MA. Association between human fetuin-A and the metabolic syndrome: data from the Heart and Soul study. Circulation 2006, 113:1760-1767. 10.1161/CIRCULATIONAHA.105.588723, 2776669, 16567568.
23. Stefan N, Fritsche A, Weikert C, Boeing H, Joost HG, Häring HU, Schulze MB. Plasma fetuin-A levels and the risk of type 2 diabetes. Diabetes 2008, 57:2762-2767. 10.2337/db08-0538, 2551687, 18633113.
24. Hayden MR, Tyagi SC, Kolb L, Sowers JR, Khanna R. Vascular ossification - calcification in metabolic syndrome, type 2 diabetes mellitus, chronic kidney disease, and calciphylaxis - calcific uremic arteriolopathy: the emerging role of sodium thiosulfate. Cardiovascular Diabetology 2005, 4:4. 10.1186/1475-2840-4-4, 1079905, 15777477.
25. Baumann M, Richart T, Sollinger D, Pelisek J, Roos M, Kouznetsova T, Eckstein HH, Heemann U, Staessen JA. Association between carotid diameter and the advanced glycation endproduct Nε-Carboxymethyllysine (CML). Cardiovascular Diabetology 2009, 8:45. 10.1186/1475-2840-8-45, 2733133, 19660101.
26. Merx MW, Schäfer C, Westenfeld R, Brandenburg V, Hidajat S, Weber C, Ketteler M, Jahnen-Dechent W. Myocardial stiffness, cardiac remodeling, and diastolic dysfunction in calcification-prone fetuin-A-deficient mice. J Am Soc Nephrol 2005, 16:3357-3364. 10.1681/ASN.2005040365, 16177000.
27. Ix JH, Wassel CL, Kanaya AM, Vittinghoff E, Johnson KC, Koster A, Cauley JA, Harris TB, Cummings SR, Shlipak MG. Fetuin-A and incident diabetes mellitus in older persons.; Health ABC Study. JAMA 2008, 300:182-188. 10.1001/jama.300.2.182, 2779582, 18612115.
28. Rittig K, Thamer C, Haupt A, Machann J, Peter A, Balletshofer B, Fritsche A, Haring HU, Stefan N. High Plasma Fetuin-A is associated with Increased Carotid Intima-media Thickness in a Middle-Aged Population. Atherosclerosis 2009, 207:341-342. 10.1016/j.atherosclerosis.2009.05.018, 19615685.
29. Mori K, Ikari Y, Jono S, Emoto M, Shioi A, Koyama H, Shoji T, Ishimura E, Inaba M, Hara K, Nishizawa Y. Fetuin-A is associated with calcified coronary artery disease. Coron Artery Dis 2010, 21:281-5. 10.1097/MCA.0b013e32832fe5d5, 20436350.
30. Danesh J, Wheeler JG, Hirschfield GM, Eda S, Eiriksdottir G, Rumley A, Lowe GD, Pepys MB, Gudnason V. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 2004, 350:1387-1397. 10.1056/NEJMoa032804, 15070788.
31. von Eynatten M, Hamann A, Twardella D, Nawroth PP, Brenner H, Rothenbacher D. Atherogenic dyslipidaemia but not total- and high-molecular weight adiponectin are associated with the prognostic outcome in patients with coronary heart disease. Eur Heart J 2008, 29:1307-1315. 10.1093/eurheartj/ehn135, 18390868.